This study showed thatPLS3gene expression was increased 9.8 times in our SMA type III patient (P12 with SMN1 gene exon 7/8 homozygous deletion andSMN2gene exon 7/8 without an increased copy number) compared with other patients and the healthy controls. This evidence concerns the gene SMN1 and spinal muscular atrophy, type III.